Nowozin Claudia, Wahnschaffe Amely, Rodenbeck Andrea, de Zeeuw Jan, Hädel Sven, Kozakov Ruslan, Schöpp Heinz, Münch Mirjam, Kunz Dieter
Sleep Research and Clinical Chronobiology; Institute of Physiology, Charité - University Medicine Berlin, Berlin. Germany.
Clinic for Sleep & Chronomedicine, St. Hedwig Hospital, Berlin. Germany.
Curr Alzheimer Res. 2017;14(10):1042-1052. doi: 10.2174/1567205014666170523094526.
At the beginning of this century, a novel photopigment, melanopsin, was discovered in a sub-class of retinal ganglion cells and its action spectrum was described. Shortly after, it became evident that melanopsin is a major contributor to non-visual eye-mediated effects of light on e.g. the circadian, neuroendocrine and neurobehavioral systems. First applied studies pointed out that these non-visual effects of light are relevant for wellbeing, performance and general health. A standardized measurement metric for these nonvisual effects does not exist, but would ease application. Such a metric termed as 'melanopic lux' has been recently introduced and was shown to be superior to describe non-visual effects in animal studies compared to standard metrics.
We aimed at showing some validity of melanopic lux in humans using a seminaturalistic setting. Therefore, we analyzed the impact of different lighting conditions on melatonin suppression and subjective sleepiness by calculating effective illuminance based on single photopigment sensitivities. We retrospectively analyzed data from our laboratory, where young participants were exposed to a total of 19 different polychromatic lighting conditions, for 30 minutes in the evening, one hour prior to habitual bedtime. Saliva samples for melatonin concentration measures and subjective sleepiness were regularly assessed. The photopic illuminance of all lighting conditions ranged from 3 to 604 lx. Stepwise for- and backward regression analyses showed that melanopic lux was the best predictor for changes in melatonin concentrations (but not subjective sleepiness); R²=0.16 (p<0.05). In addition, we found a significant dose-response relationship between melanopic lux and changes in melatonin concentrations for 18 different lighting conditions (adjusted R²=0.52; p=0.004), similarly to what was previously reported for photopic lux.
Our results indicate some new relevance for the application of melanopic lux as an additional metric to predict non-visual light effects of electrical light sources for nursing homes, work places, and homes.
本世纪初,在一类视网膜神经节细胞中发现了一种新型光色素——黑素视蛋白,并描述了其作用光谱。此后不久,很明显黑素视蛋白是光对昼夜节律、神经内分泌和神经行为系统等非视觉眼部介导效应的主要贡献者。最初的应用研究指出,光的这些非视觉效应与幸福感、工作表现和总体健康相关。目前不存在用于这些非视觉效应的标准化测量指标,但这将便于应用。最近引入了一种称为“黑素视亮度”的指标,与标准指标相比,该指标在动物研究中显示出在描述非视觉效应方面更具优势。
我们旨在通过半自然环境展示黑素视亮度在人类中的一些有效性。因此,我们根据单一光色素敏感性计算有效照度,分析不同光照条件对褪黑素抑制和主观嗜睡的影响。我们回顾性分析了来自我们实验室的数据,在那里年轻参与者在习惯就寝时间前一小时,于晚上接触总共19种不同的多色光照条件,持续30分钟。定期评估用于测量褪黑素浓度的唾液样本和主观嗜睡情况。所有光照条件的明视觉照度范围为3至604勒克斯。逐步向前和向后回归分析表明,黑素视亮度是褪黑素浓度变化的最佳预测指标(但不是主观嗜睡);R² = 0.16(p < 0.05)。此外,我们发现18种不同光照条件下黑素视亮度与褪黑素浓度变化之间存在显著的剂量反应关系(调整后R² = 0.52;p = 0.004),这与之前关于明视觉照度的报道类似。
我们的结果表明,黑素视亮度作为一种额外指标,在预测养老院、工作场所和家庭中电光源的非视觉光效应方面具有一些新的相关性。